These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8253492)

  • 1. Evaluation of BR-16 A (Mentat) in cognitive and behavioural dysfunction of mentally retarded children--a placebo-controlled study.
    Dave UP; Chauvan V; Dalvi J
    Indian J Pediatr; 1993; 60(3):423-8. PubMed ID: 8253492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nootropic effect of BR-16A (Mentat), a psychotropic herbal formulation, on cognitive deficits induced by prenatal undernutrition, postnatal environmental impoverishment and hypoxia in rats.
    Bhattacharya SK
    Indian J Exp Biol; 1994 Jan; 32(1):31-6. PubMed ID: 8045602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The family system of moderately mentally retarded children.
    Shulman S; Margalit M; Gadish O; Stuchiner N
    J Ment Defic Res; 1990 Aug; 34 ( Pt 4)():341-50. PubMed ID: 2398490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychotropic drug treatment among learning-disabled, educable mentally retarded, and seriously emotionally disturbed students.
    Cullinan D; Gadow KD; Epstein MH
    J Abnorm Child Psychol; 1987 Dec; 15(4):469-77. PubMed ID: 3437084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychiatric illness among the mentally retarded. A swedish population study.
    Göstason R
    Acta Psychiatr Scand Suppl; 1985; 318():1-117. PubMed ID: 3893045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized controlled double-blind trial of optimal dose methylphenidate in children and adolescents with severe attention deficit hyperactivity disorder and intellectual disability.
    Simonoff E; Taylor E; Baird G; Bernard S; Chadwick O; Liang H; Whitwell S; Riemer K; Sharma K; Sharma SP; Wood N; Kelly J; Golaszewski A; Kennedy J; Rodney L; West N; Walwyn R; Jichi F
    J Child Psychol Psychiatry; 2013 May; 54(5):527-35. PubMed ID: 22676856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind, placebo controlled, crossover trial of carbamazepine in overactive, severely mentally handicapped patients.
    Reid AH; Naylor GJ; Kay DS
    Psychol Med; 1981 Feb; 11(1):109-13. PubMed ID: 7208734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attention deficit-hyperactivity disorder among mentally retarded children.
    Fee VE; Matson JL; Benavidez DA
    Res Dev Disabil; 1994; 15(1):67-79. PubMed ID: 8190973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylphenidate, cognition, and epilepsy: A 1-month open-label trial.
    Adams J; Alipio-Jocson V; Inoyama K; Bartlett V; Sandhu S; Oso J; Barry JJ; Loring DW; Meador KJ
    Epilepsia; 2017 Dec; 58(12):2124-2132. PubMed ID: 28990169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fenfluramine and methylphenidate in children with mental retardation and attention deficit hyperactivity disorder: laboratory effects.
    Aman MG; Kern RA; McGhee DE; Arnold LE
    J Autism Dev Disord; 1993 Sep; 23(3):491-506. PubMed ID: 8226583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychopathological manifestations of children with intellectual disabilities according to their cognitive and adaptive behavior profile.
    Tremblay KN; Richer L; Lachance L; Côté A
    Res Dev Disabil; 2010; 31(1):57-69. PubMed ID: 19700260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind administration of methylphenidate to mentally retarded children with attention deficit disorder; a preliminary study.
    Varley CK; Trupin EW
    Am J Ment Defic; 1982 May; 86(6):560-6. PubMed ID: 7102728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimal brain dysfunction (neurological impairment) in children.
    Werry JS
    N Z Med J; 1974 Aug; 80(521):94-100. PubMed ID: 4608527
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of methylphenidate in paediatric traumatic brain injury.
    Hornyak JE; Nelson VS; Hurvitz EA
    Pediatr Rehabil; 1997; 1(1):15-7. PubMed ID: 9689233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic control of aberrant behavior in the mentally retarded: toward a more rational approach.
    Baumeister AA; Sevin JA
    Neurosci Biobehav Rev; 1990; 14(3):253-62. PubMed ID: 2234605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The differential validity of hyperactivity/attention deficits and conduct problems among mentally retarded children.
    Fee VE; Matson JL; Moore LA; Benavidez DA
    J Abnorm Child Psychol; 1993 Feb; 21(1):1-11. PubMed ID: 8463499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thioridazine in the treatment of mentally retarded children. (A four-year retroactive evaluation).
    Pregelj S; Barkauskas A
    Can Psychiatr Assoc J; 1967 Apr; 12(2):213-5. PubMed ID: 6040449
    [No Abstract]   [Full Text] [Related]  

  • 18. Assessment of depression in mentally retarded adolescents.
    Benavidez DA; Matson JL
    Res Dev Disabil; 1993; 14(3):179-88. PubMed ID: 8316681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and pattern of drug treatment for behavior and seizure disorders of TMR students.
    Gadow KD; Kalachnik J
    Am J Ment Defic; 1981 May; 85(6):588-95. PubMed ID: 7270572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioural studies on BR-16A (Mentat), a herbal psychotropic formulation.
    Bhattacharya SK
    Indian J Exp Biol; 1994 Jan; 32(1):37-43. PubMed ID: 8045603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.